The recommendations listed in this CPG are, whenever possible, evidence based. In April
2013, an extensive evidence review was conducted, which included a literature review …

This overview provides a guideline for the management of stable ischemic heart disease. It
represents the work of a primary and secondary panel of participants from across Canada …

Objectives: The aim of this study was to report the long-term clinical outcomes after
percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary …

Background: The results of SYNTAX trial have been reported based on “corelab” calculated
SS (cSS). It has been shown that reproducibility of SS is better among the core laboratory …

Objectives: This study sought to evaluate the impact of anatomic and procedural variables
on the outcome of the unprotected left main coronary artery (uLMCA) itself after drug-eluting …

The aims of the present study were to examine whether unresectable hepatocellular
carcinoma (HCC) patients treated with initial dose of sorafenib of 400 mg/day (half‑dose …

Objectives: We aimed at comparing the clinical outcomes of the patients who underwent
percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction …

Endovascular stents and stent grafts are increasingly used to treat a variety of
cardiovascular diseases and these endovascular devices have gained popularity …

Henry H. Ting, Barry F. Uretsky and Duminda N. Wijeysundera Garvan C. Kane, Joseph E.
Marine, M. Timothy Nelson, Crystal C. Spen Page 1 Henry H. Ting, Barry F. Uretsky and …

Objectives: The goal of this study was to assess the immediate and long-term outcomes in
patients undergoing percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) in …